World Drug Discovery Contract Research Markets - A Strategic Analysis of Research Opportunities in Top Ten Segments

World Drug Discovery Contract Research Markets - A Strategic Analysis of Research Opportunities in Top Ten Segments

 

RELEASE DATE
07-Oct-2003
REGION
Global
Research Code: 4084-01-00-00-00
SKU: HC00080-GL-MR_02808
AvailableYesPDF Download

$3,950.00

Special Price $2,962.50 save 25 %

In stock
SKU
HC00080-GL-MR_02808

$3,950.00

$2,962.50save 25 %

DownloadLink
ENQUIRE NOW

Description

Managing the drug discovery process and technologies has become one of the top challenges faced by the global pharma industry in the recent past; herein lies the opportunity for a spate of companies focusing on contract research in drug discovery. This report presents the opportunities in the top ten segments, where basic research/drug discovery is outsourced globally. The segments covered include outsourcing of research in oncology, central nervous system, autoimmune/inflammation, cardiovascular, infectious diseases, broad-based screening, chemistry, genomic targets, metabolism, and gene therapy.

Table of Contents

Overview

  • Introduction
  • Scope of Report

Challenges

  • Challenges
  • Establishing Credibility
  • Developing Strategic Fit between Outsourcers and CRO
  • Moving up the Value Chain

Drivers

  • Market Drivers
  • Global R&D Productivity
  • Cost Advantages Leading to Growth in Outsourcing
  • Increase in Time and Labor Intensive R&D Processes

Restraints

  • Market Restraints
  • Lack of Strong IPR Protection
  • Lack of Domain Expertise Limiting CR Opportunities
  • Unavailability of World-Class Infrastructure and Manpower

Oncology

Central Nervous System (CNS)

Autoimmune/Inflammation

Cardiovascular (CVS)

  • Overview
  • AMGEN
  • Pfizer
  • GlaxoSmithKline
  • Hoffmann-La Roche
  • Johnson & Johnson

Infectious Diseases

  • Overview
  • Amgen
  • GlaxoSmithKline
  • Taisho Pharmaceuticals
  • Eli Lilly
  • Novartis AG

Broad-based Screening

  • Overview
  • Eli Lilly
  • Suntory Pharmaceutical
  • Procter & Gamble
  • Encysive Pharmaceuticals
  • Novartis AG

Chemistry

  • Overview
  • Schering-Plough Corporation
  • Bayer AG
  • GlaxoSmithKline
  • Eli Lilly
  • Chiron Corporation

Genomic Targets

  • Overview
  • Pfizer
  • Hoffmann-La Roche
  • GlaxoSmithKline
  • Abbott Laboratories
  • Immuno-Designed Molecules SA

Metabolism

  • Overview
  • Pfizer
  • Procter & Gamble
  • Eli Lilly
  • Merck & Co
  • Novartis AG

Gene Therapy

  • Overview
  • Novartis AG
  • Aventis Pharmaceuticals
  • Eli Lilly
  • Bayer AG
  • Pfizer
Related Research
Managing the drug discovery process and technologies has become one of the top challenges faced by the global pharma industry in the recent past; herein lies the opportunity for a spate of companies focusing on contract research in drug discovery. This report presents the opportunities in the top ten segments, where basic research/drug discovery is outsourced globally. The segments covered include outsourcing of research in oncology, central nervous system, autoimmune/inflammation, cardiovascular, infectious diseases, broad-based screening, chemistry, genomic targets, metabolism, and gene therapy.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 4084-01-00-00-00
Is Prebook No